[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Remicade Biosimilar Market Professional Survey Report 2018

January 2018 | 107 pages | ID: G692BC302C4EN
QYResearch

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies Remicade Biosimilar in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
  • Teva Pharmaceutical Industries
  • Synthon Pharmaceuticals
  • LG Life Sciences
  • Novartis (Sandoz)
  • Celltrion
  • Biocon
  • Hospira
  • Merck Serono (Merck Group)
  • Biogen idec Inc.
  • Genentech (Roche Group)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • 100mg/10ml
  • 500mg/50ml
By Application, the market can be split into
  • Blood Disorders
  • Oncology Diseases
By Regions, this report covers (we can add the regions/countries as you want)
  • North America
  • China
  • Europe
  • Southeast Asia
  • Japan
  • India
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Remicade Biosimilar Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF REMICADE BIOSIMILAR

1.1 Definition and Specifications of Remicade Biosimilar
  1.1.1 Definition of Remicade Biosimilar
  1.1.2 Specifications of Remicade Biosimilar
1.2 Classification of Remicade Biosimilar
  1.2.1 100mg/10ml
  1.2.2 500mg/50ml
1.3 Applications of Remicade Biosimilar
  1.3.1 Blood Disorders
  1.3.2 Oncology Diseases
  1.3.3 Application
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF REMICADE BIOSIMILAR

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Remicade Biosimilar
2.3 Manufacturing Process Analysis of Remicade Biosimilar
2.4 Industry Chain Structure of Remicade Biosimilar

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF REMICADE BIOSIMILAR

3.1 Capacity and Commercial Production Date of Global Remicade Biosimilar Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Remicade Biosimilar Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Remicade Biosimilar Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Remicade Biosimilar Major Manufacturers in 2016

4 GLOBAL REMICADE BIOSIMILAR OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Remicade Biosimilar Capacity and Growth Rate Analysis
  4.2.2 2016 Remicade Biosimilar Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Remicade Biosimilar Sales and Growth Rate Analysis
  4.3.2 2016 Remicade Biosimilar Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Remicade Biosimilar Sales Price
  4.4.2 2016 Remicade Biosimilar Sales Price Analysis (Company Segment)

5 REMICADE BIOSIMILAR REGIONAL MARKET ANALYSIS

5.1 North America Remicade Biosimilar Market Analysis
  5.1.1 North America Remicade Biosimilar Market Overview
  5.1.2 North America 2012-2017E Remicade Biosimilar Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Remicade Biosimilar Sales Price Analysis
  5.1.4 North America 2016 Remicade Biosimilar Market Share Analysis
5.2 China Remicade Biosimilar Market Analysis
  5.2.1 China Remicade Biosimilar Market Overview
  5.2.2 China 2012-2017E Remicade Biosimilar Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Remicade Biosimilar Sales Price Analysis
  5.2.4 China 2016 Remicade Biosimilar Market Share Analysis
5.3 Europe Remicade Biosimilar Market Analysis
  5.3.1 Europe Remicade Biosimilar Market Overview
  5.3.2 Europe 2012-2017E Remicade Biosimilar Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Remicade Biosimilar Sales Price Analysis
  5.3.4 Europe 2016 Remicade Biosimilar Market Share Analysis
5.4 Southeast Asia Remicade Biosimilar Market Analysis
  5.4.1 Southeast Asia Remicade Biosimilar Market Overview
  5.4.2 Southeast Asia 2012-2017E Remicade Biosimilar Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Remicade Biosimilar Sales Price Analysis
  5.4.4 Southeast Asia 2016 Remicade Biosimilar Market Share Analysis
5.5 Japan Remicade Biosimilar Market Analysis
  5.5.1 Japan Remicade Biosimilar Market Overview
  5.5.2 Japan 2012-2017E Remicade Biosimilar Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Remicade Biosimilar Sales Price Analysis
  5.5.4 Japan 2016 Remicade Biosimilar Market Share Analysis
5.6 India Remicade Biosimilar Market Analysis
  5.6.1 India Remicade Biosimilar Market Overview
  5.6.2 India 2012-2017E Remicade Biosimilar Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Remicade Biosimilar Sales Price Analysis
  5.6.4 India 2016 Remicade Biosimilar Market Share Analysis

6 GLOBAL 2012-2017E REMICADE BIOSIMILAR SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Remicade Biosimilar Sales by Type
6.2 Different Types of Remicade Biosimilar Product Interview Price Analysis
6.3 Different Types of Remicade Biosimilar Product Driving Factors Analysis
  6.3.1 100mg/10ml of Remicade Biosimilar Growth Driving Factor Analysis
  6.3.2 500mg/50ml of Remicade Biosimilar Growth Driving Factor Analysis

7 GLOBAL 2012-2017E REMICADE BIOSIMILAR SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Remicade Biosimilar Consumption by Application
7.2 Different Application of Remicade Biosimilar Product Interview Price Analysis
7.3 Different Application of Remicade Biosimilar Product Driving Factors Analysis
  7.3.1 Blood Disorders of Remicade Biosimilar Growth Driving Factor Analysis
  7.3.2 Oncology Diseases of Remicade Biosimilar Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF REMICADE BIOSIMILAR

8.1 Teva Pharmaceutical Industries
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Teva Pharmaceutical Industries 2016 Remicade Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Teva Pharmaceutical Industries 2016 Remicade Biosimilar Business Region Distribution Analysis
8.2 Synthon Pharmaceuticals
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Synthon Pharmaceuticals 2016 Remicade Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Synthon Pharmaceuticals 2016 Remicade Biosimilar Business Region Distribution Analysis
8.3 LG Life Sciences
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 LG Life Sciences 2016 Remicade Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 LG Life Sciences 2016 Remicade Biosimilar Business Region Distribution Analysis
8.4 Novartis (Sandoz)
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Novartis (Sandoz) 2016 Remicade Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Novartis (Sandoz) 2016 Remicade Biosimilar Business Region Distribution Analysis
8.5 Celltrion
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Celltrion 2016 Remicade Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Celltrion 2016 Remicade Biosimilar Business Region Distribution Analysis
8.6 Biocon
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Biocon 2016 Remicade Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Biocon 2016 Remicade Biosimilar Business Region Distribution Analysis
8.7 Hospira
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Hospira 2016 Remicade Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Hospira 2016 Remicade Biosimilar Business Region Distribution Analysis
8.8 Merck Serono (Merck Group)
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Merck Serono (Merck Group) 2016 Remicade Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Merck Serono (Merck Group) 2016 Remicade Biosimilar Business Region Distribution Analysis
8.9 Biogen idec Inc.
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Biogen idec Inc. 2016 Remicade Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Biogen idec Inc. 2016 Remicade Biosimilar Business Region Distribution Analysis
8.10 Genentech (Roche Group)
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Genentech (Roche Group) 2016 Remicade Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Genentech (Roche Group) 2016 Remicade Biosimilar Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF REMICADE BIOSIMILAR MARKET

9.1 Global Remicade Biosimilar Market Trend Analysis
  9.1.1 Global 2017-2022 Remicade Biosimilar Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Remicade Biosimilar Sales Price Forecast
9.2 Remicade Biosimilar Regional Market Trend
  9.2.1 North America 2017-2022 Remicade Biosimilar Consumption Forecast
  9.2.2 China 2017-2022 Remicade Biosimilar Consumption Forecast
  9.2.3 Europe 2017-2022 Remicade Biosimilar Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Remicade Biosimilar Consumption Forecast
  9.2.5 Japan 2017-2022 Remicade Biosimilar Consumption Forecast
  9.2.6 India 2017-2022 Remicade Biosimilar Consumption Forecast
9.3 Remicade Biosimilar Market Trend (Product Type)
9.4 Remicade Biosimilar Market Trend (Application)

10 REMICADE BIOSIMILAR MARKETING TYPE ANALYSIS

10.1 Remicade Biosimilar Regional Marketing Type Analysis
10.2 Remicade Biosimilar International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Remicade Biosimilar by Region
10.4 Remicade Biosimilar Supply Chain Analysis

11 CONSUMERS ANALYSIS OF REMICADE BIOSIMILAR

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL REMICADE BIOSIMILAR MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Remicade Biosimilar
Table Product Specifications of Remicade Biosimilar
Table Classification of Remicade Biosimilar
Figure Global Production Market Share of Remicade Biosimilar by Type in 2016
Figure 100mg/10ml Picture
Table Major Manufacturers of 100mg/10ml
Figure 500mg/50ml Picture
Table Major Manufacturers of 500mg/50ml
Table Applications of Remicade Biosimilar
Figure Global Consumption Volume Market Share of Remicade Biosimilar by Application in 2016
Figure Blood Disorders Examples
Table Major Consumers in Blood Disorders
Figure Oncology Diseases Examples
Table Major Consumers in Oncology Diseases
Figure Market Share of Remicade Biosimilar by Regions
Figure North America Remicade Biosimilar Market Size (Million USD) (2012-2022)
Figure China Remicade Biosimilar Market Size (Million USD) (2012-2022)
Figure Europe Remicade Biosimilar Market Size (Million USD) (2012-2022)
Figure Southeast Asia Remicade Biosimilar Market Size (Million USD) (2012-2022)
Figure Japan Remicade Biosimilar Market Size (Million USD) (2012-2022)
Figure India Remicade Biosimilar Market Size (Million USD) (2012-2022)
Table Remicade Biosimilar Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Remicade Biosimilar in 2016
Figure Manufacturing Process Analysis of Remicade Biosimilar
Figure Industry Chain Structure of Remicade Biosimilar
Table Capacity and Commercial Production Date of Global Remicade Biosimilar Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Remicade Biosimilar Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Remicade Biosimilar Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Remicade Biosimilar Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Remicade Biosimilar 2012-2017
Figure Global 2012-2017E Remicade Biosimilar Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Remicade Biosimilar Market Size (Value) and Growth Rate
Table 2012-2017E Global Remicade Biosimilar Capacity and Growth Rate
Table 2016 Global Remicade Biosimilar Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Remicade Biosimilar Sales (K Units) and Growth Rate
Table 2016 Global Remicade Biosimilar Sales (K Units) List (Company Segment)
Table 2012-2017E Global Remicade Biosimilar Sales Price (USD/Unit)
Table 2016 Global Remicade Biosimilar Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Remicade Biosimilar 2012-2017E
Figure North America 2012-2017E Remicade Biosimilar Sales Price (USD/Unit)
Figure North America 2016 Remicade Biosimilar Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Remicade Biosimilar 2012-2017E
Figure China 2012-2017E Remicade Biosimilar Sales Price (USD/Unit)
Figure China 2016 Remicade Biosimilar Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Remicade Biosimilar 2012-2017E
Figure Europe 2012-2017E Remicade Biosimilar Sales Price (USD/Unit)
Figure Europe 2016 Remicade Biosimilar Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Remicade Biosimilar 2012-2017E
Figure Southeast Asia 2012-2017E Remicade Biosimilar Sales Price (USD/Unit)
Figure Southeast Asia 2016 Remicade Biosimilar Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Remicade Biosimilar 2012-2017E
Figure Japan 2012-2017E Remicade Biosimilar Sales Price (USD/Unit)
Figure Japan 2016 Remicade Biosimilar Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Remicade Biosimilar 2012-2017E
Figure India 2012-2017E Remicade Biosimilar Sales Price (USD/Unit)
Figure India 2016 Remicade Biosimilar Sales Market Share
Table Global 2012-2017E Remicade Biosimilar Sales (K Units) by Type
Table Different Types Remicade Biosimilar Product Interview Price
Table Global 2012-2017E Remicade Biosimilar Sales (K Units) by Application
Table Different Application Remicade Biosimilar Product Interview Price
Table Teva Pharmaceutical Industries Information List
Table Product A Overview
Table Product B Overview
Table 2016 Teva Pharmaceutical Industries Remicade Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Teva Pharmaceutical Industries Remicade Biosimilar Business Region Distribution
Table Synthon Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Synthon Pharmaceuticals Remicade Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Synthon Pharmaceuticals Remicade Biosimilar Business Region Distribution
Table LG Life Sciences Information List
Table Product A Overview
Table Product B Overview
Table 2015 LG Life Sciences Remicade Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 LG Life Sciences Remicade Biosimilar Business Region Distribution
Table Novartis (Sandoz) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis (Sandoz) Remicade Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Novartis (Sandoz) Remicade Biosimilar Business Region Distribution
Table Celltrion Information List
Table Product A Overview
Table Product B Overview
Table 2016 Celltrion Remicade Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Celltrion Remicade Biosimilar Business Region Distribution
Table Biocon Information List
Table Product A Overview
Table Product B Overview
Table 2016 Biocon Remicade Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Biocon Remicade Biosimilar Business Region Distribution
Table Hospira Information List
Table Product A Overview
Table Product B Overview
Table 2016 Hospira Remicade Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Hospira Remicade Biosimilar Business Region Distribution
Table Merck Serono (Merck Group) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck Serono (Merck Group) Remicade Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Merck Serono (Merck Group) Remicade Biosimilar Business Region Distribution
Table Biogen idec Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Biogen idec Inc. Remicade Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Biogen idec Inc. Remicade Biosimilar Business Region Distribution
Table Genentech (Roche Group) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Genentech (Roche Group) Remicade Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Genentech (Roche Group) Remicade Biosimilar Business Region Distribution
Figure Global 2017-2022 Remicade Biosimilar Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Remicade Biosimilar Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Remicade Biosimilar Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Remicade Biosimilar Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Remicade Biosimilar Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Remicade Biosimilar Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Remicade Biosimilar Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Remicade Biosimilar Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Remicade Biosimilar Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Remicade Biosimilar by Type 2017-2022
Table Global Consumption Volume (K Units) of Remicade Biosimilar by Application 2017-2022
Table Traders or Distributors with Contact Information of Remicade Biosimilar by Region


More Publications